| __timestamp | Gilead Sciences, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2983000000 | 20140000 |
| Thursday, January 1, 2015 | 3426000000 | 37173000 |
| Friday, January 1, 2016 | 3398000000 | 48616000 |
| Sunday, January 1, 2017 | 3878000000 | 108488000 |
| Monday, January 1, 2018 | 4056000000 | 244622000 |
| Tuesday, January 1, 2019 | 4381000000 | 287000000 |
| Wednesday, January 1, 2020 | 5151000000 | 354000000 |
| Friday, January 1, 2021 | 5246000000 | 186000000 |
| Saturday, January 1, 2022 | 5673000000 | 151000000 |
| Sunday, January 1, 2023 | 6090000000 | 232600000 |
| Monday, January 1, 2024 | 6091000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. Over the past decade, Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Gilead Sciences saw a steady increase in SG&A costs, rising by approximately 104%, reflecting their expansive growth and strategic investments. In contrast, Ionis Pharmaceuticals experienced a more volatile trajectory, with a peak in 2020, followed by a decline, indicating a more cautious approach to scaling operations.
Gilead's SG&A expenses in 2023 were nearly 27 times higher than those of Ionis, highlighting the disparity in their operational scales. This data not only underscores the financial strategies of these companies but also provides insights into their market positioning and future potential.
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Ionis Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and BeiGene, Ltd.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Incyte Corporation
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Pharming Group N.V.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Alkermes plc
Gilead Sciences, Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Gilead Sciences, Inc. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
argenx SE and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
BioMarin Pharmaceutical Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Madrigal Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs Ionis Pharmaceuticals, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs TG Therapeutics, Inc.: SG&A Expense Trends